...
首页> 外文期刊>Oncogene >MiR-135a functions as a selective killer of malignant glioma
【24h】

MiR-135a functions as a selective killer of malignant glioma

机译:MiR-135a作为恶性神经胶质瘤的选择性杀手

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Glioma is the most common and fatal primary brain tumor. Thus far, therapeutic strategies to efficiently and specifically antagonize glioma are limited and poorly developed. Here we report that glia-enriched miR-135a, a microRNA that is dramatically downregulated in malignant glioma and correlated with the pathological grading, is capable of inducing mitochondria-dependent apoptosis of malignant glioma by regulating various genes including STAT6 , SMAD5 and BMPR2 , as well as affecting the signaling pathway downstream. Moreover, this lethal effect is selectively towards malignant glioma cells, but not neurons and glial cells, through a novel mechanism. Our findings suggest an important role of miR-135a in glioma etiology and provide a potential candidate for malignant glioma therapy.
机译:脑胶质瘤是最常见和致命的原发性脑肿瘤。迄今为止,有效和特异性拮抗神经胶质瘤的治疗策略是有限的并且开发不充分。在这里我们报告说,富含神经胶质的miR-135a是一种在恶性神经胶质瘤中显着下调并与病理分级相关的microRNA,它能够通过调节各种基因(包括STAT6和)诱导线粒体依赖性细胞凋亡。 > SMAD5和 PR2,以及影响下游的信号通路。而且,这种致死作用是通过一种新机制选择性地针对恶性神经胶质瘤细胞,而非神经元和神经胶质细胞。我们的发现表明,miR-135a在神经胶质瘤病因中具有重要作用,并为恶性神经胶质瘤治疗提供了潜在的候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号